ALEMBIC
Back to Balance Sheet
|
ALEMBIC Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹28 Cr | ₹32 Cr | ₹35 Cr | ₹60 Cr | ₹47 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ALEMBIC ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹60 Cr |
| Mar2021 | ₹47 Cr |
How is Deferred Tax Assets / Liabilities of ALEMBIC Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | -11.86 | |
| Mar2024 | ₹32 Cr | -7.60 | |
| Mar2023 | ₹35 Cr | -42.40 | |
| Mar2022 | ₹60 Cr | 29.71 | |
| Mar2021 | ₹47 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ALEMBIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC | ₹1,931.1 Cr | -5.3% | -19.1% | -12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
ALEMBIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | -5.3% |
-19.1% |
-12.9% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses